Trial · NCT03304457
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Serum brain derived neurotrophic factor (BDNF) | 6 weeks | the change in serum level of BDNF from baseline after treatment with lurasidone or olanzapine |
| Secondary | serum nerve growth factor (NGF) | 6 weeks | the change in serum level of NGF from baseline after treatment with lurasidone or olanzapine |
| Secondary | Serum Neurotrophin 3 (NT3) | 6 weeks | the change in serum level of NT3 from baseline after treatment with lurasidone or olanzapine |
| Secondary | PANSS score | 6 weeks | To determine the association (if any) between change in serum neurotrophic factor and PANSS score |
| Secondary | Social and occupational functioning assessment scale (SOFAS) | 6 weeks | To determine the association (if any) between change in serum neurotrophic factor and SOFAS (Social and occupational functioning assessment scale) score |
| Secondary | Serum hsCRP | 6 weeks | to assess cardiovascular risk in schizophrenia |
| Secondary | Serum Insulin | 6 weeks | to assess insulin resistance |
| Secondary | LDL/HDL ratio | 6 weeks | to assess dyslipidemia and cardiovascular risk |
| Secondary | Fasting blood sugar | 6 weeks | to assess dysglycemia |
| Secondary | Glycosylated Hemoglobin (HbA1c) | 6 weeks | to assess dysglycemia |
| Secondary | High Density Lipoprotein (HDL) | 6 week | to assess dyslipidemia |
| Secondary | Low Density Lipoprotein (LDL) | 6 week | to assess dyslipidemia |
| Secondary | Very Low Density Lipoprotein (VLDL) | 6 week | to assess dyslipidemia |
| Secondary | Serum Triglyceride | 6 weeks | to assess dyslipidemia |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03304457/registered